Stride Robotics

PUBLIC

Name	Stride Robotics
Tagline	Developing a lightweight, high-power prosthetic knee using artificial muscle technology.
Headquarters	Pittsburgh, United States
Founded	2023 [PitchBook, 2026]
Business Model	Hardware + Software
Industry	Deeptech
Technology	Robotics
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2+)

Links

PUBLIC

This section provides direct links to the company's primary public-facing channels.

• Website: https://www.striderobotics.io/
• LinkedIn: https://www.linkedin.com/company/stride-robotics

Executive Summary

PUBLIC

Stride Robotics is developing a powered prosthetic knee designed to be lighter than the biological limb it replaces, a technical benchmark that, if achieved, would address a fundamental limitation in current assistive devices and merit investor attention [Stride Robotics, retrieved 2024]. The company was founded in 2023 in Pittsburgh, emerging from nearly a decade of academic research into artificial muscle actuators and high-performance robotics [Stride Robotics, retrieved 2024]. Its core product wedge rests on translating this artificial muscle technology into a commercial prosthetic that promises to be lighter, quieter, and more functional than existing powered options [Be-YOU-tiful Adaptive Warrior, retrieved 2026].

The founding team is led by Revanth Damerla, whose prior work as Co-Founder and CEO of Grasp Robotics at the University of Michigan focused on developing artificial muscle technology for robotic hands, providing a direct technical lineage for Stride's approach [DBusiness Magazine, retrieved 2026]; [UM - Innovation Partnerships, retrieved 2026]. No priced funding rounds or institutional investors have been publicly confirmed, placing the company in an early, likely pre-seed development phase with a hardware-plus-software business model. The primary watch points over the next 12-18 months will be the transition from prototype to a validated minimum viable product, the securing of initial institutional capital to fund hardware development, and the articulation of a clear commercial pathway in a complex, reimbursement-driven market.

Data Accuracy: YELLOW -- Core product claims and founder background are sourced; funding and commercial metrics are unverified.

Taxonomy Snapshot

Axis	Classification
Business Model	Hardware + Software
Industry / Vertical	Deeptech
Technology Type	Robotics
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2+)

Company Overview

PUBLIC

Stride Robotics formed in 2023 in Pittsburgh, Pennsylvania, to address what its founders saw as a fundamental failure in powered prosthetic devices [PitchBook, 2026]. The company's origin is framed as a direct response to the limitations of existing technology, which it describes as too heavy, short-lived, and limited, leaving many amputees reliant on passive solutions [Stride Robotics, 2024]. This founding thesis appears to be a direct translation of academic research into a commercial venture.

The technical foundation for the startup is rooted in nearly a decade of prior work by co-founder and CEO Revanth Damerla. Before Stride Robotics, Damerla was the co-founder and CEO of Grasp Robotics, a University of Michigan spin-out focused on developing artificial muscle technology for robotic hands [DBusiness Magazine, 2026]; [UM - Innovation Partnerships, 2026]. That earlier company's work on actuators designed to mimic human strength and dexterity provides a clear technical lineage for Stride's focus on lightweight, high-power artificial muscles for prosthetics.

Public milestones beyond the founding date and the articulation of its core mission are not yet available. The company's website indicates it is in an active product development stage, specifically "building the first powered prosthetic knee lighter than the limb it replaces" [Stride Robotics, 2024]. No information on corporate structure, subsequent legal filings, or commercial partnerships has been verified from public sources.

Data Accuracy: YELLOW -- Company founding and mission confirmed by PitchBook and company website; founder background corroborated by multiple independent sources. No independent verification of corporate status or milestones.

Product and Technology

MIXED The core proposition is a fundamental re-engineering of the powered prosthetic knee, targeting the weight and performance limitations that have historically confined advanced devices to research labs. According to the company's own framing, the goal is to build "the first powered prosthetic knee lighter than the limb it replaces" by utilizing "lightweight, high-power artificial muscle technology" [Stride Robotics, retrieved 2024]. This suggests a design philosophy that prioritizes a net reduction in carried mass for the user, a critical factor for adoption and daily wear.

Technical details remain closely held, but the focus on artificial muscles points to an actuator technology distinct from the electric motors or hydraulic systems common in existing powered limbs. The founder's prior work at Grasp Robotics involved developing actuators that could increase strength fourfold while maintaining speed, size, and weight, a performance profile directly relevant to a prosthetic knee [DBusiness Magazine, 2026]. The product is described as aiming to be lighter, quieter, more affordable, and more functional than current powered options [Be-YOU-tiful Adaptive Warrior, 2026].

Public information does not yet detail a specific software layer or user interface. The broader mission to improve mobility for amputees implies an integrated hardware-software system is likely under development, but its features and control paradigms are not publicly specified. The company appears to be in an active prototyping and development phase, with no announced commercial product name, specifications, or regulatory milestones.

Data Accuracy: YELLOW -- Core product claims are sourced from the company website and a third-party blog; technical foundation is corroborated by founder's prior published research.

Market Research

PUBLIC The market for advanced prosthetic limbs is being reshaped by a confluence of demographic pressure, technological maturation, and a growing push for improved quality of life, moving beyond basic functionality.

Third-party market sizing specific to powered prosthetic knees is not publicly available in the cited research. However, analogous data for the broader advanced prosthetic and orthotic sector provides a relevant frame of reference. The global prosthetics and orthotics market was valued at approximately $6.8 billion in 2022 and is projected to grow to over $10 billion by 2030, according to a report from Grand View Research [Grand View Research]. This growth is driven by an aging global population, rising prevalence of vascular diseases and diabetes leading to limb loss, and increasing trauma cases from accidents and conflict.

Key demand drivers extend beyond simple population statistics. There is a documented shift in patient expectations, with a growing emphasis on devices that restore not just mobility but also natural gait, energy efficiency, and the ability to engage in active lifestyles [Be-YOU-tiful Adaptive Warrior, 2026]. This creates a pull for powered solutions over passive ones. Simultaneously, technological tailwinds from adjacent fields like robotics, materials science, and battery technology are lowering the barriers to developing lighter, more powerful actuators, which has historically been a primary constraint.

Adjacent and substitute markets include the larger mobility assistance sector, which encompasses robotic exoskeletons for rehabilitation and powered orthotics. For instance, Stride Bionics, a related project cited in research, is developing an AI-powered robotic ankle exoskeleton for stroke survivors, indicating a potential expansion path into neurological gait impairment [AI for Good]. This suggests the underlying artificial muscle technology could have applications beyond lower-limb amputation, addressing a broader population with mobility challenges. Regulatory forces are a constant factor, with devices requiring FDA clearance or CE marking, a process that adds significant time and cost to commercialization but also serves as a barrier to entry once achieved.

Global Prosthetics & Orthotics Market 2022 | 6.8 | $B
Projected Market 2030 | 10.2 | $B

The projected growth of the broader market, while not specific to powered knees, indicates a receptive and expanding addressable base for any solution that can meet higher performance thresholds at a viable cost.

Data Accuracy: YELLOW -- Market sizing is drawn from an analogous sector report; specific segmentation for powered prosthetic knees is not confirmed.

Competitive Landscape

MIXED Stride Robotics is entering a specialized hardware market where competition is defined by a stark divide between established medical device incumbents and a small cohort of venture-backed startups targeting specific performance gaps.

The competitive map for powered prosthetic knees is not crowded with direct, like-for-like challengers, but is instead segmented by technology approach, price point, and regulatory pathway. Incumbent players like Ottobock and Össur dominate the global market for prosthetic components, including microprocessor-controlled knees, with decades of clinical validation, established reimbursement codes, and global distribution networks [PUBLIC]. Their products, however, are often cited as heavy, expensive, and functionally limited compared to a biological limb. A newer wave of startups, such as Bionic Power (focused on energy harvesting) and Psyonic (developing advanced multi-articulating hands and arms), are tackling adjacent problems in bionics but do not appear to have a commercial powered knee offering. This leaves a clear wedge for a startup like Stride Robotics that is explicitly targeting the weight and performance limitations of current powered options.

Stride Robotics's stated edge today is technical and originates from its founders' research lineage. The company's positioning rests on a proprietary actuator technology,lightweight, high-power artificial muscles,derived from nearly a decade of academic work, most visibly through CEO Revanth Damerla's prior venture, Grasp Robotics [DBusiness Magazine, 2026]; [UM - Innovation Partnerships, 2026]. This is a perishable edge, contingent on translating lab-scale prototypes into a reliable, manufacturable, and clinically tested product before a well-funded competitor either develops similar tech or acquires it. The company's early-stage status and lack of disclosed funding or partnerships mean it does not yet hold defensible advantages in capital, distribution, or regulatory clearance, which are the traditional moats in medtech.

The company's most significant exposure is to the entrenched advantages of the incumbents, not to other startups. Ottobock and Össur control the crucial channels of certified prosthetists and orthotists (CPOs) who fit devices, and they have mastered the complex reimbursement landscape with Medicare and private insurers [PUBLIC]. For Stride Robotics to succeed, it must not only build a better knee but also navigate this commercial and regulatory gauntlet, which requires capital and partnerships it has not yet demonstrated. Furthermore, the mention of a related project, Stride Bionics, developing an AI-powered ankle exoskeleton for stroke survivors, suggests a potential broadening of scope [AI for Good, 2026]; [stridebionics.com, 2026]. While this could open a larger addressable market, it also risks diluting focus and resources at a critical early stage, exposing the company to competitors who are singularly focused on a single application.

The most plausible 18-month competitive scenario hinges on proof of technical viability and securing a lead investor. If Stride Robotics can publicly demonstrate a functional prototype that materially undercuts the weight of an Ottobock C-Leg while matching or exceeding its power, it becomes an attractive acquisition target for a major incumbent seeking to leapfrog its own R&D. In this scenario, the "winner" would be a first-mover startup that validates the artificial muscle approach in prosthetics. The "loser" would be other early-stage bionics startups still searching for product-market fit, as validation in one niche could redirect investor appetite and partnership interest toward the proven technical path.

Data Accuracy: YELLOW -- Competitive analysis is inferred from company positioning and known market structure; no direct competitor financials or product specs are publicly available for comparison.

Opportunity

PUBLIC The prize for Stride Robotics is the creation of a new performance standard in lower-limb prosthetics, moving a segment of the market from passive, compensatory devices to active, biomimetic systems that could meaningfully improve quality of life for millions of amputees.

The headline opportunity is to become the category-defining hardware platform for powered lower-limb prosthetics, establishing a new benchmark for weight, power, and cost that makes active devices a viable first choice rather than a last resort. This outcome is reachable because the core technical wedge,artificial muscle actuators developed over nearly a decade of academic research,addresses the fundamental physical constraints that have historically limited adoption: weight, noise, and battery life [Stride Robotics, retrieved 2024]. The company’s stated goal of a knee “lighter than the limb it replaces” directly targets the primary user complaint against existing powered options, which are often described as too heavy and cumbersome [Be-YOU-tiful Adaptive Warrior, retrieved 2026]. If the technology delivers on its performance claims, it could reset expectations for what a prosthetic limb can be, moving the category beyond passive mechanics.

Growth would likely follow one of several concrete paths, each hinging on a specific technical or commercial catalyst.

Scenario	What happens	Catalyst	Why it's plausible
Knee-first, then full limb system	The powered knee becomes the anchor product, followed by integrated ankle and hip modules to create a complete powered lower-limb system.	Successful clinical validation and FDA clearance of the initial knee device.	The founder’s prior work at Grasp Robotics focused on modular actuator systems for robotic hands, suggesting a platform approach to joint design [DBusiness Magazine, retrieved 2026]. The knee is the most complex and high-value joint in lower-limb prosthetics, making it a logical beachhead.
Partnership with a major OEM	A large incumbent orthopedic company (e.g., Össur, Ottobock) licenses the artificial muscle technology or co-develops a next-generation product line.	Demonstrated prototype superiority in key metrics (weight, torque, efficiency) over existing motor-based systems.	The prosthetics industry has a history of acquiring or partnering with innovative startups to refresh product portfolios. The technology’s origin in university research (Grasp Robotics at the University of Michigan) provides a track record of formal technology transfer [UM - Innovation Partnerships, retrieved 2026].
Expansion into neurological rehab	The core actuation technology is adapted into lightweight exoskeletons or gait trainers for stroke survivors and others with neurological impairments.	Validation of the “Stride Bionics” ankle exoskeleton concept for stroke rehabilitation [AI for Good, retrieved 2026].	The underlying need for lightweight, powerful assistance is similar across prosthetic and rehabilitation markets. Early public positioning under the “Stride Bionics” name indicates exploration of this adjacent application [AI for Good, retrieved 2026].

Compounding for Stride Robotics would manifest as a data and design flywheel specific to medical hardware. Early clinical deployments would generate proprietary datasets on real-world gait patterns, loading conditions, and user preferences. This data could feed back into iterative design improvements and software personalization, creating a product that becomes more attuned to user needs with each generation. Furthermore, establishing a trusted brand and a installed base of devices could create a classic razor-and-blades model, where the high-margin recurring revenue comes from servicing, software upgrades, and consumable components for a long-lived hardware platform. While there is no public evidence this flywheel is yet in motion, the academic research foundation suggests a methodology geared toward data-driven design iteration.

The size of the win can be framed by looking at a public comparable. Össur, a leading global prosthetics and orthotics company, has a market capitalization of approximately $3 billion. Its product mix includes both passive and microprocessor-controlled knees. A successful new entrant that captures even a single-digit percentage of the global market for lower-limb prosthetics,estimated in the billions of dollars annually,could support a valuation in the hundreds of millions, assuming it achieves material market share and premium pricing. If the “partnership with a major OEM” scenario plays out, an acquisition at a premium to that valuation is a plausible exit. This is a scenario-based outcome, not a forecast, but it illustrates the magnitude of the opportunity if the technology proves superior and commercially viable.

Data Accuracy: YELLOW -- Core opportunity thesis is inferred from company claims and founder background; adjacent market exploration (Stride Bionics) is cited from a third-party event page.

Sources

PUBLIC

1. [Stride Robotics, retrieved 2024] Stride Robotics , https://www.striderobotics.io/

2. [PitchBook, 2026] Stride Robotics 2026 Company Profile: Valuation, Funding & Investors | PitchBook , https://pitchbook.com/profiles/company/550895-86

3. [Be-YOU-tiful Adaptive Warrior, 2026] New Age Powered Prosthetics: A Leap Toward Real Mobility - Be-YOU-tiful Adaptive Warrior , https://www.bawarrior360.com/2026/05/13/new-age-powered-prosthetics-a-leap-toward-real-mobility/

4. [DBusiness Magazine, 2026] Grasp Robotics Developing Artificial Muscle at University of Michigan - DBusiness Magazine , https://www.dbusiness.com/hustle-and-muscle-articles/grasp-robotics-developing-artificial-muscle-at-university-of-michigan/

5. [UM - Innovation Partnerships, 2026] Grasp Robotics, U-M Startup with Focus on Prosthetics Innovation, Rings in License Agreement with Startup Bell Ceremony - UM - Innovation Partnerships , https://innovationpartnerships.umich.edu/stories/grasp-robotics-u-m-startup-with-focus-on-prosthetics-innovation-rings-in-license-agreement-with-startup-bell-ceremony/

6. [AI for Good, 2026] Stride Bionics - AI for Good , https://aiforgood.itu.int/speaker/stride-bionics/

7. [stridebionics.com, 2026] Stride Bionics | Intelligent Mobility Solutions , https://www.stridebionics.com/

8. [Grand View Research] Global Prosthetics and Orthotics Market Size, Share & Trends Analysis Report , https://www.grandviewresearch.com/industry-analysis/prosthetics-and-orthotics-market